Cargando…

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

Cervical cancer is a leading cause of cancer death among women in low-income countries, with ∼25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, M, Kim, J J, Albero, G, de Sanjosé, S, Clifford, G, Bosch, F X, Goldie, S J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480962/ https://www.ncbi.nlm.nih.gov/pubmed/18612311 http://dx.doi.org/10.1038/sj.bjc.6604462

Ejemplares similares

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Cervical intraepithelial neoplasia 3, coinfected with HPV-16 and -18--case report.
por: Park, J. S., et al.
Publicado: (1993)

Cervical and Oral Screening for HR-HPV types 16 and 18 among Sudanese Women Cervical Lesions
por: Elasbali, Abdelbaset Mohamed, et al.
Publicado: (2012)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

HPV16 genetic variation and the development of cervical cancer worldwide
por: Cornet, I, et al.
Publicado: (2013)

Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China
por: Zhang, Qian, et al.
Publicado: (2017)

Making sense of information about HPV in cervical screening: a qualitative study
por: Waller, J, et al.
Publicado: (2005)

Clinical relevance of partial HPV16/18 genotyping in stratifying HPV‐positive women attending routine cervical cancer screening: a population‐based cohort study
por: Gori, S, et al.
Publicado: (2021)

Population-based e-records to evaluate HPV triage of screen-detected atypical squamous cervical lesions in Catalonia, Spain, 2010–15
por: de Sanjosé, Silvia, et al.
Publicado: (2018)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia
por: Mu, Lin, et al.
Publicado: (2020)

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
por: Ogilvie, Gina S, et al.
Publicado: (2010)

Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008)

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study
por: Ogilvie, G S, et al.
Publicado: (2012)

HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus
por: Nicolás‐Párraga, Sara, et al.
Publicado: (2016)

HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005
por: Félix, Ana, et al.
Publicado: (2016)

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
por: Hooi, Desiree J, et al.
Publicado: (2018)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

The study protocol of the evaluation for the preventive efficacy of the HPV vaccine for persistent HPV16/18 infection in Japanese adult women: the HAKUOH study
por: Kurokawa, Tetsuji, et al.
Publicado: (2020)

Differences in the risk of cervical cancer and human papillomavirus infection by education level
por: Franceschi, S, et al.
Publicado: (2009)

Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women
por: Insinga, Ralph P, et al.
Publicado: (2007)

Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa
por: Tsu, Vivien Davis, et al.
Publicado: (2018)

Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping
por: Padhy, Radha Rani, et al.
Publicado: (2020)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
por: Castellsagué, X, et al.
Publicado: (2011)

Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign
por: Vu, Lan TH, et al.
Publicado: (2013)

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
por: Bhuyan, Prakash K., et al.
Publicado: (2020)

HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
por: Szarewski, A, et al.
Publicado: (2011)

HPV-based cervical cancer screening in Nicaragua: from testing to treatment
por: Holme, Francesca, et al.
Publicado: (2020)

HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples
por: Lagström, Sonja, et al.
Publicado: (2021)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
por: Khazaei, Sedigheh, et al.
Publicado: (2016)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2agfps5p7c1dqovsi4afn0e34n